Health
A drug from Merck has received FDA approval to expand its use in cervical cancer
The U.S. Food and Drug Administration on Friday approved the expanded use of Merck & Co’s blockbuster immunotherapy Keytruda in combination with chemoradiation therapy to
Oxford begins human trials of Nipah virus vaccine
Oxford University announced the start of human trials of an experimental vaccine against the brain-inflammatory Nipah virus, which has caused outbreaks in the Indian state
U.S. sets record enrollment in Obamacare plans
More than 20 million Americans have signed up for health insurance through the Affordable Care Act (ACA) marketplace so far this year, the highest number
Pakistan seizes poisonous solvent used in cough syrup
Pakistan has seized a shipment of contaminated propylene glycol solvent labelled as manufactured by Dow Chemical, Thailand, the national drug regulatory authority said Thursday. Dow
Sanofi to sponsor the Olympics in its bid for brand renewal
Sanofi hopes Olympic Games sponsorship will allow it to attract new talent, reward existing staff and shake off its conservative image. The French drugmaker said
Salmonella tests at melon plant in Mexico come back negative amid outbreak
Tests for traces of salmonella at a melon processing plant in Mexico came back negative amid an investigation into a deadly outbreak in the United
China approves Eisai and Biogen’s treatment for Alzheimer’s disease
Eisai and Biogen said that their Alzheimer’s disease drug Lecembi has won approval in China, the third country after the US and Japan. Both companies
BioNTech expects to return to revenue growth by 2025
BioNTech said it would return to revenue growth by 2025, predicting that the ongoing decline of its COVID-19 vaccine business would bottom out and that
The US FDA has refused to approve Astellas’ stomach cancer drug
Japan’s Astellas Pharma said the US Food and Drug Administration has refused to approve its experimental drug to treat a type of stomach cancer, citing
GSK boosts respiratory portfolio with $1.4bn Aiolos Bio deal
GSK said on Tuesday it will acquire asthma drug maker Aiolos Bio in a deal worth up to $1.4bn, as the British drugmaker boosts its